| 3/26/2025 | HY | Market Commentary: Chuck E. Cheese joins calendar; Bausch comes in; Starwood, goeasy lag; XPLR selling resumes
|
| 3/26/2025 | HY | Market Commentary: Distressed credits under pressure as risk-off sentiment resurfaces; Bausch notes active
|
| 3/25/2025 | HY | Market Commentary: Michaels higher; Hertz mixed; Bausch distressed bonds decline; stress cracks appear
|
| 3/25/2025 | HY | Market Commentary: Bausch Health prices megadeal; calendar grows; EZCorp outperforms
|
| 3/25/2025 | CLHY | Market Commentary: Bausch Health, M6 Midstream break; CohnReznick, Vista Global modified; Novolex accelerated
|
| 3/25/2025 | CAHY | New Issue: Bausch Health prices upsized $4.4 billion 10% seven-year secured notes at par
|
| 3/25/2025 | CAHY | Bausch Health talks upsized $4.65 billion secured notes due 2032 at 10%-10¼%
|
| 3/21/2025 | HY | Market Commentary: Chunky yield junk megadeals expected soon; Capstone, Sunoco come in; XPLR lags
|
| 3/21/2025 | HY | Market Commentary: Morning Commentary: Mohegan on deck as trade war fears send junk bonds lower
|
| 3/20/2025 | HY | Market Commentary: Hertz bonds slammed; Sunnova Energy declines; Bausch distressed bonds jump; Scripps up
|
| 3/20/2025 | HY | Market Commentary: Active junk primary prices $3.35 billion; Hertz sell-off resumes; funds add $1.09 billion
|
| 3/20/2025 | BKCADDHY | Moody's gives Bausch loans, notes Caa1
|
| 3/19/2025 | HY | Market Commentary: Bausch Health joins junk calendar, debt stack mixed on redemptions; Insulet shoots higher
|
| 3/19/2025 | CLHY | Market Commentary: Valvoline, LCI Industries, IFS break; Allwyn updates emerge; Bausch Health discloses talk
|
| 3/19/2025 | BKCADDHY | S&P ups Bausch, rates loans, notes B
|
| 3/19/2025 | BKCADDHY | S&P hikes Bausch + Lomb
|
| 3/19/2025 | CAHYLM | Bausch Health to redeem notes via proceeds of new notes, term loan
|
| 3/19/2025 | CAHY | Bausch Health starts roadshow for $4 billion secured notes due 2032; initial talk high-10% area
|
| 3/18/2025 | HY | Market Commentary: Insulet prices; Mohegan joins junk calendar; Outbrain crumbles; Hertz under pressure
|
| 3/17/2025 | HY | Market Commentary: Novolex joins shadow calendar; secondary quiet but firm; Cornerstone tanks on earnings
|
| 3/17/2025 | BKCAHY | Bausch Health expected to bring $4 billion to $5 billion of notes, loans in mid-to-late March
|
| 3/13/2025 | HY | Market Commentary: Hertz, Fortress Energy slide; Sunnova up; pharma pressured on Mallinckrodt, Endo deal
|
| 2/28/2025 | HY | Market Commentary: Olin drives by; shadow calendar eyed; WEX flat; Celanese active ahead of anticipated offering
|
| 2/28/2025 | HY | Market Commentary: iHeartCommunications declines; Bausch CCC-rated notes mixed; distressed market active
|
| 2/28/2025 | HY | Market Commentary: Morning Commentary: Junk opens flat; Olin brings $600 million drive-by notes offering
|
| 2/27/2025 | HY | Market Commentary: Altice sheds some gains; DISH softens after earnings results; Bausch mostly stronger
|
| 2/27/2025 | HY | Market Commentary: WEX prices; Nissan up on fallen-angel status; Arko under pressure; funds add $1.36 billion
|
| 2/27/2025 | CAHY | Bausch Health expected next week with benchmark notes offering to address pending maturities
|
| 2/25/2025 | HY | Market Commentary: Bausch Health notes stronger; Michaels softens in February; distressed trading grows
|
| 2/20/2025 | HY | Market Commentary: Distressed trading ramps up; Bausch bonds jump in heavy supply; Carvana paper steady
|
| 2/20/2025 | HY | Market Commentary: Amsted drives by with junk; First Quantum, Albertsons rise; funds add $1.21 billion
|
| 2/19/2025 | HY | Market Commentary: Bausch paper quiets on earnings news; Hughes Satellite bonds rally; Gray Media down
|
| 2/10/2025 | HY | Market Commentary: Bausch Health notes jump; WW notes inch forward; Ford paper sheds nearly 30 bps
|
| 2/7/2025 | HY | Market Commentary: Bausch mostly flat; wider junk spreads eyed in months ahead; Office Properties mixed
|
| 2/6/2025 | HY | Market Commentary: Bausch Health declines after sale talks end; iHeartCommunications rebounds; Scripps up
|
| 12/19/2024 | HY | Market Commentary: Distressed paper pressured; Gray TV, Michaels, Bausch lower; private defaults down
|
| 12/12/2024 | HY | Market Commentary: Distressed debt trading cools; market wary of Bausch + Lomb deal; Tullow Oil mixed
|
| 12/11/2024 | HY | Market Commentary: Bausch Health, Bausch + Lomb soften after rally in back half of year; defaults slow
|
| 11/1/2024 | HY | Market Commentary: CSC paper climbs across credit cap; Bausch notes up; risks taken off table ahead of election
|
| 9/18/2024 | HY | Market Commentary: DISH notes give back some gains; ModivCare improves; Bausch Health mostly higher
|
| 9/17/2024 | HY | Market Commentary: Michaels pressured after quarterly report; DISH mostly holds onto gains; Bausch lower
|
| 9/16/2024 | HY | Market Commentary: DISH jumps on merger talk; Bausch higher on sale chatter; ModivCare gains after update
|
| 7/25/2024 | HY | Market Commentary: Walgreens notes mixed; Bausch softens after bankruptcy rebuttal; distressed returns up
|
| 7/24/2024 | BKCADDHY | Bausch Health says it is not considering filing bankruptcy
|
| 7/12/2024 | HY | Market Commentary: Hertz extends gains; Bausch improves; Office Properties up; default forecasts lower
|
| 6/6/2024 | HY | Market Commentary: AMC notes climb as trading ramps up; iHeartCommunications bonds positive; Bausch mixed
|
| 5/29/2024 | HY | Market Commentary: Distressed names pressured; AMC notes soften; Altice drops; iHeartCommunications lower
|
| 5/6/2024 | HY | Market Commentary: Junk primary market on fire: six issuers price $4.7 billion in drive-bys; calendar grows
|
| 4/18/2024 | HY | Market Commentary: Altice soft on week with paper central in distressed trading; secondary ‘busier’
|
| 4/18/2024 | BKCADDHY | S&P bumps up Bausch Health Cos.
|
| 4/11/2024 | HY | Market Commentary: Altice notes dominate distressed space, higher on week; Bausch bonds give back gains
|
| 4/10/2024 | HY | Market Commentary: Bausch bonds lead distressed gains; iHeart steady to weaker; Cumulus Media mostly quiet
|
| 4/8/2024 | HY | Market Commentary: Bausch Health bonds gain in April; Altice France paper moves higher; secondary thins
|
| 2/5/2024 | HY | Market Commentary: Cano Health, Community Health distressed paper mostly quiet; distressed returns soft
|
| 12/18/2023 | HY | Market Commentary: WeWork bonds decline; Bausch Health paper recovers Friday losses; distressed returns soften
|
| 12/15/2023 | HY | Market Commentary: AMC bonds stronger on day, week; Bausch notes mixed; December distressed returns up
|
| 11/28/2023 | HY | Market Commentary: AMC secured paper declines; Bausch improves in thin supply; CommScope slightly better
|
| 10/19/2023 | HY | Market Commentary: Rite Aid secondary interest continues, bonds up; Bausch Health mixed; AMC soft on week
|
| 10/3/2023 | HY | Market Commentary: DISH notes slide in wide sell-off; Bausch Health declines; iHeartCommmunications drops
|
| 10/3/2023 | BKDDHY | Fitch lowers Bausch Health debt
|
| 9/20/2023 | HY | Market Commentary: Lumen bonds see strong pickup; Bausch Health mostly lower; Altice’s CSC notes mixed
|
| 9/13/2023 | HY | Market Commentary: Staples in focus, secured notes drop; Bausch Health active; Lion’s Gate paper rises
|
| 9/11/2023 | BKCAHY | Moody's gives Bausch+Lomb loan, notes B1
|
| 8/16/2023 | DDHY | Fitch sees U.S. junk bond defaults rising
|
| 8/15/2023 | HY | Market Commentary: Radiology Partners gains; Bausch Health notes soften; DISH mixed; AMC bonds lower
|
| 8/14/2023 | HY | Market Commentary: AMC bonds, stock mostly down on preferred plans; Rite Aid paper up; Bausch notes higher
|
| 7/17/2023 | HY | Market Commentary: Rite Aid paper limps back at week’s start; Altice bonds soften; Bausch Health improves
|
| 7/12/2023 | HY | Market Commentary: Bausch swings higher; Rite Aid skids after regulatory filing; DISH slips; Level 3 up
|
| 7/10/2023 | HY | Market Commentary: Bausch distressed notes mixed; AMC bonds perk up; DISH bonds decline; default events up
|
| 7/7/2023 | HY | Market Commentary: Secondary firms; Sealed Air gains; Copeland improves; Bausch outperforms
|
| 7/7/2023 | HY | Market Commentary: Bausch Health stronger; AMC theater notes better; AMC cable gains; LifePoint edges up
|
| 7/3/2023 | HY | Market Commentary: Community Health notes up; Bausch mixed; Michaels dips; QVC down; Staples better
|
| 6/20/2023 | HY | Market Commentary: Community Health secured notes improve; Bausch Health better; Rite Aid paper perks up
|
| 6/16/2023 | HY | Market Commentary: Staples declines in strong Friday supply; Mallinckrodt lower; Bausch flat; Carvana up
|
| 6/13/2023 | HY | Market Commentary: AMC, Staples distressed paper stronger; Michaels gains; Community Health, Bausch up
|
| 6/2/2023 | HY | Market Commentary: DISH bonds extend gains; Carvana higher after collapse of exchange offer; Bausch up
|
| 5/24/2023 | HY | Market Commentary: Distressed secured paper softens; Bausch, iHeartMedia, AMC lower; index returns up
|
| 5/22/2023 | HY | Market Commentary: Bausch Health gives back some gains; LifePoint notes mixed; Rite Aid bonds flat
|
| 5/19/2023 | HY | Market Commentary: DISH bonds little changed; Bausch mostly holds onto gains; iHeartMedia notes mixed
|
| 5/18/2023 | HY | Market Commentary: Bausch mostly higher; iHeartMedia bonds, CDS spreads weaken; Bed Bath & Beyond active
|
| 5/17/2023 | HY | Market Commentary: Distressed bonds with 8½% coupon lifted; Shutterfly improves; Bausch up; Qurate better
|
| 5/10/2023 | HY | Market Commentary: DISH bonds take back some losses from sell-off; Bausch paper down; distressed soft
|
| 5/2/2023 | HY | Market Commentary: First Republic notes drop; Community Health pressured after loss; Bausch paper mixed
|
| 4/19/2023 | HY | Market Commentary: Western Global Airlines notes limp back from plunge; SVB up; Bausch Health improves
|
| 4/17/2023 | HY | Market Commentary: Cano, Community Health, Bausch mixed; Rite Aid bonds improve; WeWork notes move higher
|
| 4/14/2023 | HY | Market Commentary: QVC notes lower; Bausch Health, Community Health up; WeWork improves; Talen softens
|
| 4/3/2023 | HY | Market Commentary: Bausch higher; Allen Media up; WeWork drops; Transocean gains; BB&B soft
|
| 3/10/2023 | HY | Market Commentary: SVB sinks as FDIC shuts bank, trading soars past $1 billion; Bausch, Lumen lower
|
| 3/8/2023 | HY | Market Commentary: Bausch bonds decline; WeightWatchers rallies; Bed Bath & Beyond notes stuck in teens
|
| 3/6/2023 | HY | Market Commentary: Bed Bath & Beyond falls after interest payment; QVC downtrend continues; Bausch better
|
| 2/28/2023 | BKCADDHY | S&P boosts Bausch Health
|
| 2/27/2023 | HY | Market Commentary: AMC mixed ahead of earnings post; Bausch paper active; Carvana mostly up; Lumen lower
|
| 2/24/2023 | HY | Market Commentary: Carvana mixed in strong volume; Lumen disappoints; Bausch notes mostly unchanged
|
| 2/24/2023 | BKCADDHY | S&P lowers Bausch Health
|
| 2/23/2023 | HY | Market Commentary: Anywhere Real Estate paper, CDS soften; Rite Aid quiet, CDS spreads firm; Bausch gains
|
| 2/14/2023 | HY | Market Commentary: Diamond Sports notes mixed; Diebold edges up; Lumen active; Bausch mostly declines
|
| 2/13/2023 | HY | Market Commentary: Bed Bath notes soften; Diamond Sports, Diebold up; Team Health, Bausch, Envision trade
|
| 2/10/2023 | HY | Market Commentary: Bausch, Community Health under pressure; Diamond Sports little changed; Sinclair gains
|
| 2/3/2023 | HY | Market Commentary: AMC notes mixed; Bausch Health declines in active trading; Adani claws back losses
|
| 1/31/2023 | HY | Market Commentary: AMC bonds push higher; Diamond Sports moves up; Bausch Health lower; Adani volatile
|
| 1/20/2023 | HY | Market Commentary: Diamond Sports distressed paper moves lower; Qurate Retail declines; Bausch gives back
|
| 1/6/2023 | HY | Market Commentary: Junk surges, closes week with strong gains; Ford hits 101-handle; DISH recoups losses
|
| 1/6/2023 | HY | Market Commentary: Party City notes plummet on expected bankruptcy filing; Bed Bath & Beyond sinks further
|
| 12/30/2022 | BKCVDDEMHY | Outlook 2023: Higher defaults in store across markets; distressed debt exchange leading cause
|
| 12/23/2022 | HY | Market Commentary: Market action thin, volatility down; newcomers to distressed debt space draw attention
|
| 12/22/2022 | HY | Market Commentary: Rite Aid notes remain soft, retailer’s CDS spreads tighten on week; Bausch paper lower
|
| 12/12/2022 | HY | Market Commentary: Bausch gains in active trading; AMC bonds improve; Coinbase notes shed 1 point
|
| 12/9/2022 | HY | Market Commentary: AMC notes lower in strong volume; Bausch rises; CSC paper down; Carvana stages rally
|
| 12/6/2022 | HY | Market Commentary: AMC under pressure; health care paper up, Bausch, CHS improve; Petrofac trades higher
|
| 11/10/2022 | HY | Market Commentary: AMC notes gain in heavy trading; Bausch Health paper rallies; Rite Aid notes improve
|
| 11/2/2022 | HY | Market Commentary: Drugstore, pharma paper mixed following opioid deal; Rite Aid lower; Endo, Bausch up
|
| 10/13/2022 | HY | Market Commentary: AMC lower; Credit Suisse CDS spreads firm; Rite Aid weakens; Embarq soft; Bausch down
|
| 10/7/2022 | BKCADDHY | Fitch cuts, ups Bausch Health
|
| 10/4/2022 | BKCACVDDHY | S&P ups Bausch, rates notes B-, CCC
|
| 9/30/2022 | BKCACVDDHY | S&P slices Bausch Health Cos.
|
| 9/30/2022 | BKCACVDDHY | Moody's cuts some Bausch Health ratings
|
| 9/28/2022 | HY | Market Commentary: Bausch mostly flat, quiet following exchange; QVC notes better; AT&T weak; CHS declines
|
| 9/28/2022 | CADDHYLM | Bausch Health gives final results of exchange offer, consent bid
|
| 9/20/2022 | HY | Market Commentary: Sabra declines; Toledo Hospital softens; Bausch Health paper perks up; Michaels lower
|
| 9/19/2022 | HY | Market Commentary: Transocean softens; CineMedia sinks; Bausch improves; Country Garden quiet; defaults up
|
| 9/14/2022 | HY | Market Commentary: Endo lower following stock delisting plans; Bausch mixed; CHS down; Transocean rallies
|
| 9/14/2022 | CADDHYLM | Bausch Health gives early results of exchange offer, consent bid
|
| 9/9/2022 | HY | Market Commentary: Distressed paper lifted in light secondary supply; Bausch, Staples gain; FLY notes up
|
| 9/8/2022 | HY | Market Commentary: Qurate, QVC steady following downgrade; Diversified Health soft; Bausch moves lower
|
| 9/8/2022 | CADDHYLM | Bausch Health clarifies provisions of exchange offer, consent bid
|
| 9/7/2022 | HY | Market Commentary: Bausch pharma bonds mixed, secured notes flat; Transocean higher; Party City improves
|
| 9/6/2022 | HY | Market Commentary: Bausch flat to lower; Bed Bath & Beyond paper declines; Toledo Hospital notes stable
|
| 9/2/2022 | HY | Market Commentary: Bausch mostly up in light trading; Envision softens; Team Health dips; Rite Aid mixed
|
| 9/1/2022 | HY | Market Commentary: Bausch paper declines under heavy secondary pressure; Endo lower; AMC notes soften
|
| 8/31/2022 | HY | Market Commentary: Royal Caribbean, Ford losses mount in junk trading; Bausch mixed on exchange offer
|
| 8/31/2022 | HY | Market Commentary: Bausch mixed on exchange offer; Transocean softens; Bed Bath & Beyond up on stock deal
|
| 8/31/2022 | BKCADDHY | Fitch slashes Bausch Health
|
| 8/31/2022 | BKCADDHY | Moody's cuts Bausch Health
|
| 8/31/2022 | BKCADDHY | S&P drops Bausch Health to CC
|
| 8/31/2022 | CADDHYLM | Bausch Health launches $4 billion exchange offer, consent solicitation
|
| 8/30/2022 | HY | Market Commentary: Bausch notes decline; Envision Healthcare lower; Team Health, Talen up in August
|
| 8/29/2022 | HY | Market Commentary: Endo notes trade up; CHS paper softens; Toledo Hospital improves; Bausch declines
|
| 8/26/2022 | HY | Market Commentary: Bausch paper extends weakness; Bed Bath & Beyond notes soften; Country Garden up
|
| 8/25/2022 | HY | Market Commentary: Rite Aid, Staples, Kohl’s paper, CDS spreads under pressure; Avaya higher; Bausch down
|
| 8/24/2022 | HY | Market Commentary: FXI active in junkland; Bausch under pressure; Toledo sell-off continues
|
| 8/24/2022 | HY | Market Commentary: Distressed pharmaceutical paper mixed; Bausch notes skid; Endo improves; Revlon higher
|
| 8/22/2022 | HY | Market Commentary: Junk bonds open week with losses; Ford, Royal Caribbean under water; Charter down again
|
| 8/22/2022 | BKCADDHY | Bausch Health internally transfers stock, explores strategic alternatives
|
| 8/22/2022 | HY | Market Commentary: Bed Bath & Beyond lower; AMC bonds, stock decline; CineMedia drops; Bausch down
|
| 8/18/2022 | HY | Market Commentary: Endo up after bankruptcy filing; Mallinckrodt soft; Bausch pressured; trading thin
|
| 8/17/2022 | HY | Market Commentary: Endo bonds higher; Mallinckrodt up; Bausch drops; Lannett flat; Toledo Hospital down
|
| 8/16/2022 | HY | Market Commentary: Bed Bath & Beyond rallies; AMC higher; Plains All American up; Bausch Health declines
|
| 8/12/2022 | HY | Market Commentary: AMC notes move higher; Avaya bonds shed over 3 points; Bausch Health paper improves
|
| 8/9/2022 | HY | Market Commentary: Endo mixed on potential bankruptcy; Bausch, CHS, Avaya paper declines; Envision quiet
|
| 8/9/2022 | BKBWCAHYLM | Bausch buys $481 million bonds at a discount; no debt due until 2025
|
| 8/3/2022 | HY | Market Commentary: Bausch lower in heavy trading; Transocean extends rally; Diamond Sports notes drop
|
| 8/3/2022 | BKCVHY | Fitch pares Bausch Health
|
| 8/2/2022 | HY | Market Commentary: Diebold Nixdorf up in distressed trade; Transocean higher; TPC quiet; Bausch softens
|
| 8/1/2022 | HY | Market Commentary: Bausch Health declines; Transocean gains as oil prices drop; Community Health softens
|
| 8/1/2022 | BKCACVHY | S&P cuts Bausch Health
|
| 7/29/2022 | BKCACVHY | Moody's downgrades Bausch Health
|
| 7/27/2022 | HY | Market Commentary: Pharma bonds mixed following Teva opioid settlement; Endo mostly lower; Bausch improves
|
| 7/22/2022 | HY | Market Commentary: Community Health stronger; Endo, Bausch paper improves; higher default rates forecast
|
| 7/15/2022 | HY | Market Commentary: Endo notes mixed on more missed bond payments; Bausch paper improves; Community Health up
|
| 7/14/2022 | HY | Market Commentary: Bausch paper extends losses; Endo mostly lower; Rite Aid notes flat, CDS spreads firm
|
| 7/13/2022 | HY | Market Commentary: Bausch falls over 5 points; Talen softens; Transocean nearly 10 points lower on week
|
| 6/29/2022 | HY | Market Commentary: Bed Bath & Beyond sinks on net loss, board shake-up; Community Health, Bausch lower
|
| 6/28/2022 | HY | Market Commentary: Rite Aid down after tender offer wraps; Endo higher; Bausch lower; EnLink softens
|
| 6/15/2022 | HY | Market Commentary: Revlon bonds crack 200% yield area; Rite Aid higher; Bausch down; Cooper-Standard up
|
| 6/3/2022 | HY | Market Commentary: Bausch Health bonds active; Avaya uptrend continues; At Home notes move lower
|
| 6/1/2022 | HY | Market Commentary: TPC jumps after bankruptcy filing; Bausch mixed post downgrade; AMC, Bed Bath fall
|
| 5/31/2022 | HY | Market Commentary: Bausch Health notes active; Telesat gains; Cinemark, AMC Entertainment rally continues
|
| 5/31/2022 | BKCAHY | S&P cuts Bausch Health Cos.
|
| 5/27/2022 | HY | Market Commentary: AMC extends rally; Bausch climbs; Coinbase up; Diebold steadies; Greenland plunges
|
| 5/23/2022 | HY | Market Commentary: Medline higher; Envision declines; Team Health softens; Bausch up; Transocean better
|
| 5/13/2022 | HY | Market Commentary: Bausch up; AMC higher; Diebold Nixdorf improves; Rite Aid notes, CDS spreads soften
|
| 5/13/2022 | BKCAHY | Moody's downgrades Bausch Health
|
| 5/10/2022 | CAHYLM | Bausch Health cancels redemption of 9% senior notes due 2025
|
| 4/25/2022 | CAHYLM | Bausch Health sets redemption price for 6 1/8% senior notes
|
| 4/20/2022 | BKCAHY | Fitch plans to rate Bausch + Lomb BB-, loan BB+
|
| 4/20/2022 | BKCAHY | Moody’s rates Bausch + Lomb loans Ba2
|
| 4/18/2022 | CAHYLM | Bausch Health again delays redemption of 6 1/8%, 9% senior notes
|
| 3/14/2022 | CAHYLM | Bausch Health pushes back redemption of 6 1/8%, 9% senior notes
|
| 2/24/2022 | BKBWCAHYLM | Bausch Health de-levers to 6.5x, will de-lever subsidiaries as well
|
| 2/2/2022 | HY | Market Commentary: AMC, Mednax, Boyne sell new junk; volatility returns; Bausch gains; cruise lines improve
|
| 1/31/2022 | HY | Market Commentary: Calendar builds; secondary firms; Bausch, Embecta improve; Athena struggles continue
|
| 1/28/2022 | HY | Market Commentary: ION, Covis on hold; volatile junk market ends day up, week down; athenahealth struggles
|
| 1/27/2022 | HY | Market Commentary: Junk primary has biggest session year to date; secondary trading ‘ugly’ as selling accelerates
|
| 1/27/2022 | CLHY | Market Commentary: Crocs, Embecta, Intelsat, Bausch Health, TaylorMade, athenahealth, Inspire Brands break
|
| 1/27/2022 | CAHY | New Issue: Bausch Health prices $1 billion 6 1/8% five-year secured notes at par
|
| 1/27/2022 | BKCAHY | Moody's gives Bausch Health notes Ba3
|
| 1/27/2022 | CAHY | Bausch Health to sell $1 billion five-year secured notes on Thursday
|
| 1/27/2022 | BKCAHY | Fitch rates Bausch Health notes BB
|
| 1/27/2022 | BKCAHY | S&P assigns Bausch Health notes BB
|
| 1/25/2022 | HY | Market Commentary: ION on tap; junk secondary weaker; Oxford outperforms; Medline gains; Netflix active
|
| 1/19/2022 | CLHY | Market Commentary: Griffon, Addison Group, NAB, Liberty Tire break; Arxada, System One changes surface
|
| 1/18/2022 | HY | Market Commentary: Euro junk bond primary active; Charter, Commercial Metals below par in volatile space
|
| 1/18/2022 | CLHY | Market Commentary: Griffon tweaks deal; Vaco accelerates deadline; Embecta, Syniverse, Dessert reveal talk
|
| 1/18/2022 | CAHY | Bausch Health refinancing deal to include $1 billion new secured notes; guidance mid-5% area
|
| 1/18/2022 | BKCAHY | S&P rates Bausch loans BB
|
| 1/18/2022 | BKCAHY | Fitch rates Bausch facility BB
|
| 1/18/2022 | BKCAHY | Moody's rates Bausch Health loans Ba3
|
| 1/18/2022 | CAHYLM | Bausch Health intends to issue conditional notices of redemption
|
| 1/18/2022 | CAHY | Bausch Health refinancing deal to include $1 billion new secured debt
|
| 11/18/2021 | BKCAHY | Moody's alters Bausch Health view to negative
|
| 11/12/2021 | HY | Market Commentary: TPC drops; Talen soft; Bausch, MultiPlan lower; Endo improves; Kaisa, Evergrande up
|
| 8/3/2021 | CAHYLM | Bausch Health will redeem additional $350 million 6 1/8% notes
|
| 7/1/2021 | CAHYLM | Bausch Health eyes partial redemption of 6 1/8% note due 2025
|
| 6/22/2021 | CAHYLM | Bausch Health extends tender offer for 7% secured notes due 2024 to reflect new federal holiday
|
| 6/7/2021 | CAHYLM | Bausch Health sees early tenders of $545.08 million 7% notes due 2024
|
| 5/28/2021 | HY | Market Commentary: Morning Commentary: Junk edges up amid low pre-Memorial Day liquidity; CQP marked higher
|
| 5/27/2021 | HY | Market Commentary: High yield: CQP prices; secondary quiet, unchanged; Park River on a par-handle
|
| 5/27/2021 | CAHYLM | Bausch Health to redeem C$100 million 6 1/8% notes due 2025
|
| 5/25/2021 | HY | Market Commentary: Junk market sells $4.29 billion; Bausch Health gains; Antero at a premium; Nielsen weakens
|
| 5/24/2021 | HY | Market Commentary: Primary prices $3.6 billion; forward calendar grows; Bausch unsecured tranches drop; Square active
|
| 5/24/2021 | CAHY | New Issue: Bausch Health prices $1.6 billion seven-year secured notes at par to yield 4 7/8%
|
| 5/24/2021 | BKCAHY | Fitch gives Bausch Health notes BB
|
| 5/24/2021 | CAHY | Bausch Health to sell $1.6 billion seven-year secured notes on Monday
|
| 5/24/2021 | CAHYLM | Bausch Health commences tender offer for 7% secured notes due 2024
|
| 5/24/2021 | BKCAHY | S&P assigns Bausch Health notes BB
|
| 5/24/2021 | BKCAHY | Moody's rates Bausch Health notes Ba2
|
| 5/5/2021 | BKCAHY | Fitch revises Bausch Health view to negative
|
| 5/4/2021 | HY | Market Commentary: High yield: Community Health, Coronado price; ION Trading gains; Bausch under pressure
|
| 5/4/2021 | BKCAHY | S&P alters Bausch Health view to negative
|
| 5/3/2021 | CAHYLM | Bausch Health to redeem C$100 million more 7% secured notes on June 2
|
| 4/7/2021 | CAHYLM | Bausch Health to redeem C$100 million more 7% secured notes due 2024
|
| 2/26/2021 | CAHYLM | Bausch Health to redeem C$100 million 7% senior notes due 2024
|
| 2/24/2021 | BKBWCAHY | Bausch repays $900 million debt in 2020, targets $1 billion for 2021
|
| 2/22/2021 | CAHYLM | Bausch Health to redeem C$100 million of 7% senior notes due 2024
|
| 1/13/2021 | BKBWCAHY | Bausch Health aims to cut leverage via debt paydowns, higher EBITDA
|
| 12/24/2020 | HY | Market Commentary: Primary closes the books on 2020; liquidity at a standstill
|
| 12/1/2020 | BKBWCAHY | Bausch management seeks to cut leverage as company is ‘very levered’
|
| 11/19/2020 | HY | Market Commentary: Primary prices over $6 billion; Bausch in focus; Diamond Sports gains; funds up $490 million
|
| 11/18/2020 | HY | Market Commentary: Bausch Health megadeal, Syneos price; NRG in focus; MGM at a premium
|
| 11/18/2020 | CAHYLM | Bausch Health eyes redemption of 4½%, 5½% notes due 2023
|
| 11/18/2020 | CAHY | New Issue: Bausch Health prices upsized $2 billion senior notes in two tranches
|
| 11/18/2020 | CAHYLM | Bausch Health to redeem all €1.5 billion 4.5% senior notes due 2023
|
| 11/18/2020 | CAHY | Bausch Health to sell $1.75 billion of notes in two parts on Wednesday
|
| 11/18/2020 | BKCAHY | S&P assigns Bausch Health notes B
|
| 11/18/2020 | BKCAHY | Moody’s gives Bausch Health notes B3
|
| 11/18/2020 | BKCAHY | Fitch rates Bausch Health notes B
|
| 10/29/2020 | CAHYLM | Bausch Health to redeem 5 7/8% notes, C$50 million of 5½% notes
|
| 8/31/2020 | CAHYLM | Bausch Health to redeem C$100 million 5 7/8% senior notes due 2023
|
| 5/12/2020 | HY | Market Commentary: Viking Cruises, OneMain/Springleaf, Match, Radian price; Encompass adds-on; Bausch dominates, Lamar flat
|
| 5/11/2020 | HY | Market Commentary: Bausch Health, Lamar Media, PowerTeam price; Ford breaks par; Callon Petroleum gains
|
| 5/11/2020 | BKCAHY | S&P rates Bausch Health notes B
|
| 5/11/2020 | CAHY | New Issue: Bausch Health prices upsized $1.5 billion 6¼% notes due 2029 at par
|
| 5/11/2020 | BKCAHY | Fitch rates Bausch Health notes B
|
| 5/11/2020 | BKCAHY | Moody’s rates Bausch Health notes B3
|
| 5/11/2020 | CAHYLM | Bausch Health conditionally calls $1.25 billion 6½% notes due 2022
|
| 5/11/2020 | CAHY | Bausch Health talks $1.25 billion notes due 2029 to yield 6¼%-6½%; pricing Monday
|
| 3/3/2020 | HY | Market Commentary: Morning Commentary: Junk opens unchanged; new Cleveland-Cliffs 6¾% notes trade higher
|
| 3/2/2020 | BKCAHYLM | Bausch cancels plans for new notes, loan refinancing, redemption
|
| 2/21/2020 | BKCAHY | S&P gives Bausch Health loan, notes BB
|
| 2/20/2020 | BKCAHY | Fitch rates Bausch Health Americas facility, notes BB
|
| 2/19/2020 | CAHYLM | Bausch Health will redeem 6½% notes due 2022, 7% notes due 2024
|
| 2/19/2020 | CAHY | Bausch Health plans to issue C$3.25 billion of new notes
|
| 2/12/2020 | CAHYLM | Bausch Health to redeem C$100 million 5½% notes due 2023
|
| 12/23/2019 | HY | Market Commentary: Cincinnati Bell skyrockets on buyout news; Calpine, Bausch, CenturyLink active
|
| 12/19/2019 | HY | Market Commentary: Calpine prices new offering, recent issues unchanged; Bausch active; Vivint, Rite Aid gain
|
| 12/18/2019 | HY | Market Commentary: Bausch Health’s new notes jump, outstanding notes trade down; Alliance Data flat; Intelsat gains
|
| 12/18/2019 | CAHYLM | Bausch Health calls $1.24 billion 5 7/8% notes due 2023
|
| 12/18/2019 | HY | Market Commentary: Morning Commentary: Bausch tranches trade to smart premiums; 2019 deal calendar empty
|
| 12/17/2019 | HY | Market Commentary: Alliance Data, Bausch Health, Qorvo add-on price; Archrock in focus; oil patch firms
|
| 12/17/2019 | CAHY | New Issue: Bausch Health prices upsized $2.5 billion notes in two tranches
|
| 12/17/2019 | CAHY | S&P gives Bausch Health notes B
|
| 12/17/2019 | CAHY | Moody’s assigns B3 to Bausch notes
|
| 12/17/2019 | CAHY | Fitch rates Bausch notes B
|
| 12/17/2019 | CAHY | Bausch Health to shop $1.25 billion two-part senior notes offering on Tuesday investor call
|
| 12/16/2019 | HY | Moody’s cuts Petra Diamonds
|
| 12/16/2019 | CAHY | S&P upgrades Bausch Health
|
| 11/4/2019 | BKBWCAHY | Bausch pays down debt in search of ‘more reasonable’ capital structure
|
| 10/1/2019 | HY | Market Commentary: Shutterfly prices, Alliant on tap; Bausch, U.S. Steel lower, WeWork sees respite; recent issues active
|
| 9/3/2019 | CAHYLM | Bausch Health to reduce debt by $200 million via paydown, redemption
|
| 5/23/2019 | CAHYLM | Bausch Health tender offer for 5½% notes, 5 7/8% notes oversubscribed
|
| 5/14/2019 | HY | Market Commentary: Morning Commentary: CNG markets secured notes; VistaJet, GasLog offerings on deck
|
| 5/13/2019 | HY | Market Commentary: Eldorado on tap; Bausch Health weakens; Charter below par; Weatherford, Teva down
|
| 5/10/2019 | HY | Market Commentary: Bausch Health trades up, Century Communities, Charter lag; Tronox drops post-earnings
|
| 5/10/2019 | HY | Market Commentary: Morning Commentary: United Group notes on deck; Thursday deals hug modest premiums
|
| 5/9/2019 | HY | Market Commentary: Bausch Health, Century Communities, Charter price; Virgin Media lags; funds lose $212 million
|
| 5/9/2019 | CAHY | New Issue: Bausch Health prices $1.5 billion senior notes in two tranches
|
| 5/9/2019 | CAHY | S&P rates Bausch Health notes B-
|
| 5/9/2019 | CAHY | Moody's rates Bausch Health notes B3
|
| 5/9/2019 | CAHY | Bausch Health to sell $1.5 billion of notes in two parts on Thursday
|
| 5/9/2019 | CAHYLM | Bausch launches tender offer for up to $1.5 billion of 2023 notes
|
| 5/9/2019 | CAHY | Fitch rates Bausch notes B
|
| 5/6/2019 | BKBWCAHY | Bausch Health retires $158 million debt in Q1, plans to boost EBITDA
|
| 5/2/2019 | CAHY | Fitch upgrades Bausch Health
|
| 3/8/2019 | CAHYLM | Bausch Health calls 2021 notes, announces early tender results
|
| 3/8/2019 | CAHYLM | Bausch Health announces early results of tender offers for notes
|
| 2/27/2019 | HY | Market Commentary: Morning Commentary: Dean Foods, Weight Watchers, Hertz trade lower following earnings
|
| 2/25/2019 | HY | Market Commentary: Bausch trades up; Windstream mixed, Uniti gains on bankruptcy filing; Multi-Color jumps on buyout
|
| 2/25/2019 | HY | Market Commentary: Morning Commentary: Junk rallies into new week; Bausch Health bonds trading at premiums
|
| 2/25/2019 | CAHYLM | Bausch Health ups tender offer price to $1.5 billion for three notes
|
| 2/25/2019 | BKCAHY | S&P rates Bausch Health
|
| 2/22/2019 | HY | Market Commentary: Bausch prices, outstanding issues active; USA Compression soars; Windstream’s losses mount
|
| 2/22/2019 | CAHY | New Issue: Bausch Health prices upsized $1.5 billion notes in two tranches
|
| 2/22/2019 | BKCAHY | Moody’s rates Bausch Health notes Ba2, B3
|
| 2/22/2019 | BKCAHY | Fitch rates Bausch Health notes BB-
|
| 2/22/2019 | HY | Market Commentary: Morning Commentary: Bausch Health driving by with $1.25 billion; USA Compression gains
|
| 2/22/2019 | CAHYLM | Bausch Health holds $1.25 billion tender offer for three note series
|
| 2/22/2019 | CAHY | Bausch Health to price $1.25 billion two-part notes offering Friday
|
| 1/11/2019 | HY | Market Commentary: Dun & Bradstreet, Energizer on tap; Targa up; PG&E mixed; energy rally ends; Bausch down
|
| 1/8/2019 | HY | Market Commentary: Pacific Gas & Electric in focus on downgrade to junk; energy rally continues; Hornbeck, Bausch Health gain
|
| 1/4/2019 | HY | Market Commentary: Risk-on sentiment returns; CDX sees largest single-day gain in four years; energy outperforms
|
| 1/4/2019 | HY | Market Commentary: Rite Aid notes gain despite delisting warning; California Resources issues lead oil rally
|
| 1/3/2019 | HY | Market Commentary: Neiman Marcus notes lower as creditor dispute continues; Ultra Petroleum issues fall
|
| 12/19/2018 | HY | Market Commentary: Fed takes focus; Xerox falls into junkbondland; Micron under pressure; Bausch drops
|
| 12/19/2018 | HY | Market Commentary: California Resources notes lower as oil prices recover; Digicel issues rise
|
| 12/17/2018 | HY | Market Commentary: Morning Commentary: Hospitals, pharmaceuticals trade lower in wake of ACA ruling in Texas
|
| 11/30/2018 | CAHYLM | Bausch Health to call $200 million 5 5/8% notes due 2021 on Dec. 31
|
| 11/29/2018 | HY | Market Commentary: Mercer prices; McDermott rebound continues; Westcorp drops; Bausch improves; funds lose $1.2 billion
|
| 11/27/2018 | CAHYLM | Bausch Health to redeem remaining 7½% notes due 2021 on Dec. 27
|
| 11/21/2018 | CAHYLM | Bausch Health sees $1.48 billion early tenders of 7½% notes due 2021
|
| 11/9/2018 | BKCAHY | S&P affirms Bausch Health
|
| 11/8/2018 | BKCADDHY | Moody's upgrades Bausch
|
| 11/7/2018 | CAHYLM | Bausch Health tenders, solicits consents for 7½% notes due 2021
|
| 9/26/2018 | CAHYLM | Bausch Health calls $125 million 7½% notes due 2021
|
| 8/23/2018 | BKCADDHY | Moody’s ups Bausch SGL, changes view
|
| 5/8/2018 | BKBWCAHYLM | Valeant cuts debt by $6.9 billion since 2016; ‘more work to be done’
|
